These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


542 related items for PubMed ID: 29791864

  • 1. LncRNA TUG1 interacting with miR-144 contributes to proliferation, migration and tumorigenesis through activating the JAK2/STAT3 pathway in hepatocellular carcinoma.
    Lv J, Kong Y, Gao Z, Liu Y, Zhu P, Yu Z.
    Int J Biochem Cell Biol; 2018 Aug; 101():19-28. PubMed ID: 29791864
    [Abstract] [Full Text] [Related]

  • 2. lncRNA TUG1-Mediated Mir-142-3p Downregulation Contributes to Metastasis and the Epithelial-to-Mesenchymal Transition of Hepatocellular Carcinoma by Targeting ZEB1.
    He C, Liu Z, Jin L, Zhang F, Peng X, Xiao Y, Wang X, Lyu Q, Cai X.
    Cell Physiol Biochem; 2018 Aug; 48(5):1928-1941. PubMed ID: 30092578
    [Abstract] [Full Text] [Related]

  • 3. Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma progression through regulation of miR-140-5p-TGFBR1 pathway.
    Li Y, Liu G, Li X, Dong H, Xiao W, Lu S.
    Biochem Biophys Res Commun; 2018 Sep 18; 503(4):2826-2832. PubMed ID: 30115383
    [Abstract] [Full Text] [Related]

  • 4. The long noncoding RNA NEAT1 contributes to hepatocellular carcinoma development by sponging miR-485 and enhancing the expression of the STAT3.
    Zhang XN, Zhou J, Lu XJ.
    J Cell Physiol; 2018 Sep 18; 233(9):6733-6741. PubMed ID: 29219178
    [Abstract] [Full Text] [Related]

  • 5. Long non-coding RNA DLGAP1-AS1 facilitates tumorigenesis and epithelial-mesenchymal transition in hepatocellular carcinoma via the feedback loop of miR-26a/b-5p/IL-6/JAK2/STAT3 and Wnt/β-catenin pathway.
    Lin Y, Jian Z, Jin H, Wei X, Zou X, Guan R, Huang J.
    Cell Death Dis; 2020 Jan 16; 11(1):34. PubMed ID: 31949128
    [Abstract] [Full Text] [Related]

  • 6. LncRNA DBH-AS1 facilitates the tumorigenesis of hepatocellular carcinoma by targeting miR-138 via FAK/Src/ERK pathway.
    Bao J, Chen X, Hou Y, Kang G, Li Q, Xu Y.
    Biomed Pharmacother; 2018 Nov 16; 107():824-833. PubMed ID: 30142544
    [Abstract] [Full Text] [Related]

  • 7. Long non-coding RNA FEZF1-AS1 promotes cell invasion and epithelial-mesenchymal transition through JAK2/STAT3 signaling pathway in human hepatocellular carcinoma.
    Wang YD, Sun XJ, Yin JJ, Yin M, Wang W, Nie ZQ, Xu J.
    Biomed Pharmacother; 2018 Oct 16; 106():134-141. PubMed ID: 29957463
    [Abstract] [Full Text] [Related]

  • 8. Long Noncoding RNA HOST2 Promotes Epithelial-Mesenchymal Transition, Proliferation, Invasion and Migration of Hepatocellular Carcinoma Cells by Activating the JAK2-STAT3 Signaling Pathway.
    Wu Y, Yuan T, Wang WW, Ge PL, Gao ZQ, Zhang G, Tang Z, Dang XW, Zhao YF, Zhang JY, Jiang GZ.
    Cell Physiol Biochem; 2018 Oct 16; 51(1):301-314. PubMed ID: 30453302
    [Abstract] [Full Text] [Related]

  • 9. Circ_0072088 promotes progression of hepatocellular carcinoma by activating JAK2/STAT3 signaling pathway via miR-375.
    Li L, Xiao C, He K, Xiang G.
    IUBMB Life; 2021 Sep 16; 73(9):1153-1165. PubMed ID: 34148288
    [Abstract] [Full Text] [Related]

  • 10. lncRNA TUG1 regulates angiogenesis via the miR‑204‑5p/JAK2/STAT3 axis in hepatoblastoma.
    Yuan MX, Ji CY, Gao HQ, Sheng XY, Xie WX, Yin Q.
    Mol Med Rep; 2021 Aug 16; 24(2):. PubMed ID: 34080023
    [Abstract] [Full Text] [Related]

  • 11. CircSOD2 induced epigenetic alteration drives hepatocellular carcinoma progression through activating JAK2/STAT3 signaling pathway.
    Zhao Z, Song J, Tang B, Fang S, Zhang D, Zheng L, Wu F, Gao Y, Chen C, Hu X, Weng Q, Yang Y, Tu J, Ji J.
    J Exp Clin Cancer Res; 2020 Nov 25; 39(1):259. PubMed ID: 33234142
    [Abstract] [Full Text] [Related]

  • 12. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
    Wang Y, Yang L, Chen T, Liu X, Guo Y, Zhu Q, Tong X, Yang W, Xu Q, Huang D, Tu K.
    Mol Cancer; 2019 Feb 19; 18(1):28. PubMed ID: 30782188
    [Abstract] [Full Text] [Related]

  • 13. LncRNA SNHG7 accelerates the proliferation, migration and invasion of hepatocellular carcinoma cells via regulating miR-122-5p and RPL4.
    Yang X, Sun L, Wang L, Yao B, Mo H, Yang W.
    Biomed Pharmacother; 2019 Oct 19; 118():109386. PubMed ID: 31545291
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of LncRNA ANRIL Potential in Hepatic Cancer Progression.
    Ji Y, Sun H, Liang H, Wang Y, Lu M, Guo Z, Lv Z, Ren W.
    J Environ Pathol Toxicol Oncol; 2019 Oct 19; 38(2):119-131. PubMed ID: 31679275
    [Abstract] [Full Text] [Related]

  • 15. LncRNA SNHG3 Promotes Hepatocellular Tumorigenesis by Targeting miR-326.
    Zhao Q, Wu C, Wang J, Li X, Fan Y, Gao S, Wang K.
    Tohoku J Exp Med; 2019 Sep 19; 249(1):43-56. PubMed ID: 31548493
    [Abstract] [Full Text] [Related]

  • 16. Long non-coding RNA PTTG3P functions as an oncogene by sponging miR-383 and up-regulating CCND1 and PARP2 in hepatocellular carcinoma.
    Zhou Q, Zhang W, Wang Z, Liu S.
    BMC Cancer; 2019 Jul 24; 19(1):731. PubMed ID: 31340767
    [Abstract] [Full Text] [Related]

  • 17. LINC01433 promotes hepatocellular carcinoma progression via modulating the miR-1301/STAT3 axis.
    Huang H, Bu YZ, Zhang XY, Liu J, Zhu LY, Fang Y.
    J Cell Physiol; 2019 May 24; 234(5):6116-6124. PubMed ID: 30317567
    [Abstract] [Full Text] [Related]

  • 18. In vivo and in vitro effects of microRNA-221 on hepatocellular carcinoma development and progression through the JAK-STAT3 signaling pathway by targeting SOCS3.
    Huang S, Zhou D, Li YX, Ming ZY, Li KZ, Wu GB, Chen C, Zhao YN.
    J Cell Physiol; 2019 Apr 24; 234(4):3500-3514. PubMed ID: 30370582
    [Abstract] [Full Text] [Related]

  • 19. Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway.
    Wang F, Ying HQ, He BS, Pan YQ, Deng QW, Sun HL, Chen J, Liu X, Wang SK.
    Oncotarget; 2015 Apr 10; 6(10):7899-917. PubMed ID: 25760077
    [Abstract] [Full Text] [Related]

  • 20. HOXA-AS2 Promotes Proliferation and Induces Epithelial-Mesenchymal Transition via the miR-520c-3p/GPC3 Axis in Hepatocellular Carcinoma.
    Zhang Y, Xu J, Zhang S, An J, Zhang J, Huang J, Jin Y.
    Cell Physiol Biochem; 2018 Apr 10; 50(6):2124-2138. PubMed ID: 30415263
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 28.